Literature DB >> 22781097

Clinical utility gene card for: Glanzmann thrombasthenia.

Mathieu Fiore1, Alan T Nurden, Paquita Nurden, Uri Seligsohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22781097      PMCID： PMC3449071          DOI： 10.1038/ejhg.2012.151

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  22 in total

1.  Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics.

Authors:  Tsan Xiao; Junichi Takagi; Barry S Coller; Jia-Huai Wang; Timothy A Springer
Journal:  Nature       Date:  2004-09-19       Impact factor: 49.962

2.  Rapid diagnosis of the French gypsy mutation in Glanzmann thrombasthenia using high-resolution melting analysis.

Authors:  Mathieu Fiore; Alan T Nurden; Christine Vinciguerra; Paquita Nurden; Xavier Pillois
Journal:  Thromb Haemost       Date:  2010-09-30       Impact factor: 5.249

3.  Acquired thrombasthenia due to GPIIbIIIa platelet autoantibodies in a 4-yr-old child.

Authors:  Adrian J C Bloor; Graham A Smith; Mervyn Jaswon; Norman E Parker; Willem H Ouwehand; Ri Liesner
Journal:  Eur J Haematol       Date:  2006-01       Impact factor: 2.997

Review 4.  A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO.

Authors:  Paula H B Bolton-Maggs; Elizabeth A Chalmers; Peter W Collins; Paul Harrison; Stephen Kitchen; Ri J Liesner; Adrian Minford; Andrew D Mumford; Liakat A Parapia; David J Perry; Steve P Watson; Jonathan T Wilde; Michael D Williams
Journal:  Br J Haematol       Date:  2006-12       Impact factor: 6.998

Review 5.  Genetic testing in the diagnostic evaluation of inherited platelet disorders.

Authors:  Alan T Nurden; Mathieu Fiore; Xavier Pillois; Paquita Nurden
Journal:  Semin Thromb Hemost       Date:  2009-04-30       Impact factor: 4.180

Review 6.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

7.  Glanzmann thrombasthenia: the need for epidemiological studies.

Authors:  A T Nurden
Journal:  J Thromb Haemost       Date:  2009-08-28       Impact factor: 5.824

8.  Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients.

Authors:  C Santoro; A Rago; F Biondo; L Conti; F Pulcinelli; L Laurenti; M P Perrone; E Baldacci; A Leporace; M G Mazzucconi
Journal:  Haemophilia       Date:  2010-03-24       Impact factor: 4.287

9.  Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation.

Authors:  Lena Svensson; Kimberley Howarth; Alison McDowall; Irene Patzak; Rachel Evans; Siegfried Ussar; Markus Moser; Ayse Metin; Mike Fried; Ian Tomlinson; Nancy Hogg
Journal:  Nat Med       Date:  2009-02-22       Impact factor: 53.440

Review 10.  Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.

Authors:  Giovanni Di Minno; Antonio Coppola; Matteo N D Di Minno; Man-Chiu Poon
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249
View more
  4 in total

Review 1.  Glanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options.

Authors:  Tia Solh; Ashley Botsford; Melhem Solh
Journal:  J Blood Med       Date:  2015-07-08

Review 2.  A Comprehensive Review of Congenital Platelet Disorders, Thrombocytopenias and Thrombocytopathies.

Authors:  Gisha Mohan; Srikrishna V Malayala; Parth Mehta; Mamtha Balla
Journal:  Cureus       Date:  2020-10-31

Review 3.  Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.

Authors:  Natalie Mathews; Georges-Etienne Rivard; Arnaud Bonnefoy
Journal:  J Blood Med       Date:  2021-06-11

4.  Identification of ITGA2B and ITGB3 Single-Nucleotide Polymorphisms and Their Influences on the Platelet Function.

Authors:  Qian Xiang; Shun-Dong Ji; Zhuo Zhang; Xia Zhao; Yi-Min Cui
Journal:  Biomed Res Int       Date:  2016-11-14       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.